ORKA Oruka Therapeutics, Inc.

Fundamentals / CIK 0000907654 / USD

Oruka Therapeutics, Inc. reported $1.23B in total assets and a net loss of $152.6M through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open ORKA in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2015 to 2025), reported in USD.

$0$0$0-$98.58MFY 2015 Revenue: $0FY 2015 Net Income: -$11.45M2015FY 2016 Revenue: $0FY 2016 Net Income: -$16.44M2016FY 2017 Revenue: $0FY 2017 Net Income: -$18.49M2017FY 2018 Revenue: $0FY 2018 Net Income: -$7.93M2018FY 2019 Revenue: $0FY 2019 Net Income: -$5.48M2019FY 2020 Revenue: $0FY 2020 Net Income: -$9.74M2020FY 2021 Revenue: $0FY 2021 Net Income: -$19.32M2021FY 2022 Revenue: $0FY 2022 Net Income: -$9.93M2022FY 2023 Revenue: $0FY 2023 Net Income: -$5.34M2023FY 2025 Net Income: -$105.4M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue -- $0 $0 $0 $0 $0 $0 $0 $0 $0
Research & Development $100.6M $1.01M $4.75M $13.83M $4.99M $1.83M $4.24M $14.08M $12.35M $7.06M
Total Operating Expenses $122.1M $7.30M $10.60M $19.34M $9.77M $5.81M $8.12M $18.71M $16.61M $11.46M
Operating Income -$122.1M -$7.30M -$10.60M -$19.34M -$9.77M -$5.81M -$8.12M -$18.71M -$16.61M -$11.46M
EBITDA -$122.0M -$7.28M -$10.58M -$19.32M -$9.76M -$5.80M -$8.10M -$18.68M -$16.59M -$11.44M
Interest Income $16.63M -- -- -- -- -- -- -- -- --
Interest Expense -- -- -- -- $9.0K $7.0K $8.0K $6.0K -- $4.0K
Income Before Tax -$105.4M -- -- -$19.32M -$9.75M -$5.65M -$7.96M -$18.55M -$16.44M --
Income Tax Expense -- $0 $0 $0 -$9.0K -$167K -$31K -$61K $0 $0
Net Income -$105.4M -$5.34M -$9.93M -$19.32M -$9.74M -$5.48M -$7.93M -$18.49M -$16.44M -$11.45M
Basic EPS -- -$0.37 -$0.69 -$1.39 -$2.07 -$4.15 -$10.31 -$1.77 -$1.81 -$1.82
Diluted EPS -- -$0.37 -$0.69 -$1.39 -$2.07 -$4.15 -$10.31 -$1.77 -$1.81 -$1.82
Basic Shares Outstanding -- 14.4M 14.4M 13.9M 4.7M 1.3M 769.4K 10.4M 9.1M 6.3M
Diluted Shares Outstanding -- 14.4M 14.4M 13.9M 4.7M 1.3M 769.4K 10.4M 9.1M 6.3M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Research & Development $53.70M $43.26M $29.14M $27.64M $28.99M $24.09M $19.93M $25.50M
Total Operating Expenses $62.14M $50.11M $36.43M $34.43M $34.10M $28.43M $25.09M $30.32M
Operating Income -$62.14M -$50.11M -$36.43M -$34.43M -$34.10M -$28.43M -$25.09M -$30.32M
EBITDA -$62.09M -$50.06M -$36.39M -$34.40M -$34.09M -$28.41M -$25.07M --
Interest Income $12.17M $8.90M $4.61M $4.85M $3.83M $3.86M $4.09M --
Interest Expense -- -- -- -- -- -- -- $0
Net Income -$49.97M -$41.21M -$31.82M -$29.58M -$30.28M -$24.57M -$21.00M -$25.78M
Basic EPS -- -- -- -- -- -$0.46 -$0.40 --
Diluted EPS -- -- -- -- -- -$0.46 -$0.40 --
Basic Shares Outstanding -- -- -- -- -- 42.1M 41.7M --
Diluted Shares Outstanding -- -- -- -- -- 42.1M 41.7M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Feb 6 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $46.94M $61.58M -- $37.43M $42.45M $53.36M $49.07M $8.36M $6.61M $8.70M
Short-Term Investments $290.1M $314.1M -- -- -- -- -- -- -- $3.05M
Cash & Short-Term Investments $337.0M $375.6M -- $37.43M $42.45M $53.36M $49.07M $8.36M $6.61M $11.75M
Other Current Assets -- -- -- $161K $254K $1.06M $897K $117K $169K $547K
Total Current Assets $343.9M $376.9M $1.0K $37.59M $42.70M $54.42M $49.97M $8.48M $6.78M $12.30M
Property, Plant & Equipment, Net $288K $162K -- $10K $25K $48K $21K $10K $24K $42K
Long-Term Investments $142.5M $18.07M -- -- -- -- -- -- -- --
Other Non-Current Assets $103K $43K -- $12K $18K $18K $12K $24K $24K $24K
Total Non-Current Assets $144.8M $19.15M $0 $269K $386K $503K $461K $56K $48K $66K
Total Assets $488.6M $396.0M $1.0K $37.86M $43.09M $54.92M $50.43M $8.54M $6.83M $12.37M
Accounts Payable $4.16M $3.46M -- $362K $334K $1.12M $1.77M $418K $230K $622K
Total Current Liabilities $15.37M $13.04M -- $637K $1.13M $3.50M $3.50M $926K $793K $2.07M
Total Non-Current Liabilities $1.31M $755K -- $204K $280K $383K $409K $0 $0 $20K
Total Liabilities $16.69M $13.80M $0 $841K $1.41M $3.88M $3.91M $926K $793K $2.09M
Total Debt (incl. Leases) $1.93M $968K -- $280K $383K $483K $450K $25.00M $0 $0
Common Stock $49K $37K -- $14K $14K $14K $10K $2.0K $1.0K $12K
Retained Earnings -$189.2M -$83.72M -- -$188.7M -$183.4M -$173.5M -$154.2M -$144.4M -$138.9M -$131.0M
Accumulated Other Comp. Income $546K -$41K -- -- -- -- -- -- -- -$2.0K
Total Stockholders' Equity $471.9M $382.2M $1.0K $37.02M $41.67M $51.04M $46.52M $7.61M $6.03M $10.28M
Total Equity $471.9M $382.2M $1.0K $37.02M $41.67M $51.04M $46.52M $7.61M $6.03M $10.28M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $191.5M $268.5M $49.52M $46.94M $91.25M $65.40M $83.57M $61.58M
Short-Term Investments $728.8M $605.1M $339.3M $290.1M $257.9M $263.0M $265.5M $314.1M
Cash & Short-Term Investments $920.3M $873.6M $388.8M $337.0M $349.2M $328.4M $349.1M $375.6M
Total Current Assets $941.5M $884.6M $395.2M $343.9M $355.2M $332.0M $352.1M $376.9M
Property, Plant & Equipment, Net $309K $275K $318K $288K $253K $174K $159K $162K
Long-Term Investments $286.3M $252.0M $107.1M $142.5M $151.8M $23.05M $23.95M $18.07M
Other Non-Current Assets $128K $128K $103K $103K $103K $103K $103K $43K
Total Non-Current Assets $289.5M $254.8M $109.2M $144.8M $154.1M $25.41M $25.03M $19.15M
Total Assets $1.23B $1.14B $504.5M $488.6M $509.3M $357.4M $377.1M $396.0M
Accounts Payable $14.38M $7.95M $3.66M $4.16M $2.21M $4.66M $3.54M $3.46M
Total Current Liabilities $31.78M $22.97M $16.63M $15.37M $20.97M $12.11M $11.72M $13.04M
Total Non-Current Liabilities $2.09M $1.88M $1.13M $1.31M $1.49M $1.67M $664K $755K
Total Liabilities $33.88M $24.84M $17.76M $16.69M $22.46M $13.78M $12.39M $13.80M
Total Debt (incl. Leases) $2.93M $2.55M $1.81M $1.93M $1.91M $2.33M $947K $968K
Common Stock $67K $61K $50K $49K $48K $37K $37K $37K
Retained Earnings -$312.1M -$262.2M -$221.0M -$189.2M -$159.6M -$129.3M -$104.7M -$83.72M
Accumulated Other Comp. Income -$5.04M -$1.70M -$480K $546K $185K -$27K -$6.0K -$41K
Total Stockholders' Equity $1.20B $1.11B $486.7M $471.9M $486.8M $343.6M $364.7M $382.2M
Total Equity $1.20B $1.11B $486.7M $471.9M $486.8M $343.6M $364.7M $382.2M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$105.4M -$5.34M -$9.93M -$19.32M -$9.74M -$5.48M -$7.93M -$18.49M -$16.44M -$11.45M
Depreciation & Amortization $83K $15K $20K $16K $8.0K $18K $22K $27K $24K $19K
Stock-Based Compensation $24.24M $686K $556K $497K $43K $151K $273K $458K $576K $599K
Change in Payables -- $28K -$783K -$411K $1.10M $188K -$392K -$583K $841K -$431K
Operating Cash Flow -$88.21M -$5.01M -$10.91M -$18.76M -$7.72M -$4.80M -$8.24M -$17.47M -$14.99M -$10.53M
Capital Expenditure -$209K $0 -$2.0K -$43K -$19K -$4.0K -$4.0K -$3.0K -$12K -$11K
Free Cash Flow -$88.42M -$5.01M -$10.91M -$18.80M -$7.74M -$4.80M -$8.25M -$17.48M -$15.00M -$10.54M
Purchases of Investments -$521.0M -- -- -- -- -- -- -$5.47M -- --
Investing Cash Flow -$96.75M $0 -$2.0K -$43K -$19K -$4.0K $3.05M $12.93M -$16.41M -$11K
Common Stock Issued $671K -- -- $24.07M $50.89M $7.28M $3.53M $6.55M -- $37.00M
Financing Cash Flow $170.3M $0 $0 $23.09M $48.45M $6.56M $3.10M $5.85M -- $33.99M
Net Change in Cash -$14.64M -$5.01M -$10.91M $4.29M $40.71M $1.75M -$2.09M $1.30M -- --

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$49.97M -$41.21M -$31.82M -$29.58M -$30.28M -$24.57M -$21.00M -$25.78M
Depreciation & Amortization $49K $43K $43K $28K $20K $19K $16K --
Stock-Based Compensation $9.13M $7.28M $6.97M $4.12M $10.16M $5.08M $4.88M $5.15M
Operating Cash Flow -$44.33M -$33.15M -$23.58M -$22.59M -$21.60M -$23.14M -$20.87M -$18.82M
Capital Expenditure -$83K $0 -$73K -$63K -$99K -$34K -$13K --
Free Cash Flow -$44.41M -$33.15M -$23.65M -$22.66M -$21.70M -$23.18M -$20.88M --
Purchases of Investments -$329.5M -$490.5M -$90.83M -$101.0M -$267.7M -$108.0M -$44.29M --
Investing Cash Flow -$159.4M -$410.9M -$14.44M -$22.02M -$122.4M $4.86M $42.87M --
Common Stock Issued $4.29M $4.37M $1.70M -- -- -- -- --
Financing Cash Flow $126.8M $663.0M $40.60M -- -- -- -- -$526K
Net Change in Cash -$76.95M $218.9M $2.58M -$44.32M $25.86M -$18.18M $22.00M -$349.3M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Return on Equity (ROE) -22.3% -14.4% -23.8% -37.9% -20.9% -72.0% -131.5% -180.0% -74.1% -30.1%
Return on Assets (ROA) -21.6% -14.1% -23.0% -35.2% -19.3% -64.2% -116.2% -149.5% -66.8% -28.9%
Current Ratio 22.37x 59.01x 37.72x 15.56x 14.28x 9.16x 8.55x 5.94x 8.95x 25.88x
Quick Ratio 21.92x 58.76x 37.50x 15.25x 14.02x 9.03x 8.33x 5.68x 8.83x 25.80x
Debt to Equity 0.00x 0.01x 0.01x 0.01x 0.01x 3.29x 0.00x 0.00x 0.00x 0.00x

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) -12.7% -11.9% -23.9% -22.3% -20.9% -29.1% -26.8% -21.9%
Return on Assets (ROA) -12.4% -11.7% -23.0% -21.6% -20.0% -28.0% -25.9% -21.1%
Current Ratio 29.62x 38.51x 23.76x 22.37x 16.94x 27.42x 30.03x 28.89x
Quick Ratio 28.96x 38.03x 23.38x 21.92x 16.65x 27.12x 29.78x 28.80x
Debt to Equity 0.00x 0.00x 0.00x 0.00x 0.00x 0.01x 0.00x 0.00x
Source: SEC EDGAR CompanyFacts (CIK 0000907654) · from December 31, 2004 Data through September 30, 2026 · synced Nov 20, 2026, 05:11 UTC · Open in terminal